Cryofibrinogenemia is a cryopathy in which hypersensitivity to cold is a prominent feature. Cryofibrinogenemia developed in an 18-year-old Japanese female patient during methimazole therapy for Graves' disease. She developed cryopathy (livedo reticularis, Raynaud's phenomenon and acral ulcer) and polyarthralgia during methimazole therapy, and we detected cryofibrinogen in her plasma. Her symptomsresolved after administration of prostaglandins and anticoagulants. Several reports indicate that methimazole therapy induces autoantibody-related disease. In the present case, we cannot exclude the possibility that methimazole therapy contributed to the cryofibrinogenemia. (Internal Medicine 36: 439-442, 1997) 
Introduction
The symptomsofcryopathy, a condition in which hypersensitivity to cold is a prominent feature, are livedo reticularis, Raynaud's phenomenon, purpura, and skin ulcer. This condition is seen in various diseases including cold urticaria, paroxysmal cold hemoglobinuria, cold agglutinin syndrome, cold hemolysin syndrome, cryopathy associated with collagen disease, Raynaud's disease, cryoglobulinemia, and cryofibrinogenemia. In these diseases, the cryofibrinogenemia is characterized by cryoprecipitable protein in plasma but not in serum. This is not an uncommoncondition, although most cases of cryofibrinogenemia are asymptomatic. In symptomatic cases, cold intolerance, purpura, skin ulcers, livedo reticularis, arthralgia and Raynaud's phenomenonhave been reported as symptoms of cryofibrinogenemia (1) . We report a case of Graves ' disease which developed during methimazole therapy and presented with cryofibrinogenemia with arthralgia and cryopathy (Raynaud's phenomenon, acral ulcer, livedo reticularis).
Case Report
An 18-year-old Japanese womanwho presented with Raynaud's phenomenon,acral ulcer and polyarthralgia was admittedto OsakaMedical College on March 1 , 1995. She had visited our hospital because of goiter in April 1992. Her symptoms were hand tremor, body weight loss and low grade fever. Her thyroid function test results indicated hyperthyroidism; the serum levels of thyroid hormones were high, with a free Lthyroxine (FT4) level of4.5 ng/dl, and triiodothyronine (T3) of 2.8 ng/dl, and the serum thyroid stimulating hormone (TSH) level was suppressed (<0.1 jitU/ml).
As the TSH receptor antibody testresult was positive (x80), we diagnosed her illness was Graves' disease. In May1992 she began treatment with methimazole at an initial dose of30 mg per day. In January 1 994 she developed arthralgia of the bilateral ankles and right elbow with purpura on both lower legs. Rheumatoid factor was negative, and no deformity of the joints was found. Treatment was started with acetylsalicylic acid ( 1.5 mg daily) and prednisolone (15 mg daily). Her symptoms were slightly improved, but in January 1995, when the dose ofprednisolone was reduced to 5 mg daily, the symptoms worsened again. Moreover, in February she developed livedo reticularis, Raynaud's phenomenon and acral ulcer of the left big toe, and she was readmitted to our hospital. On admission, her weight andheight were 47 kg and 160 cm, respectively, and her blood pressure, pulse rate, and body temperature was 120/72 mmHg, 75/rhin, and 37.2°C, respectively. The respiration rate was 12/min. No signs of anemia, jaundice, lymph node swelling or goiter were revealed by physical examination. Her heart sound was clear, and auscultation of the lungs revealed no rales. The abdomenwas soft and flat. Livedo reticularis was observed on both lower legs. Acral ulcer was observed on the left big toe (Fig. 1 ). Both anklejoints were swollen, warm and painful, and the right elbow joint was painful but not swollen. Thesejoints presented no deformity on the X-ray image. The chest X-ray findings on admission were normal.
The laboratory data are summarized in Table la . The urinalysis results were normal, the erythrocyte sedimentation rate was 20 mm/h, the serum C-reactive protein level was 3.24 mg/ dl, the white bloodcell count9.0x103/)J.l, hemoglobin 1 1.3 g/dl, hematocrit 35.8%, and platelet count 28.8xlO4/uJ. The serum complement levels were normal, with CH50of47.4 U/ml, C3 of 86. 1 4 mg/dl, and C4 of 30.60 mg/dl. The prothrombin time and active partial thromboplastin time were normal, but the serum fibrinogen level was elevated to 420 mg/dl. Serum protein electrophoresis revealed polyclonal hypergammaglobulinemia, with IgG, IgA, and IgM of2,287, 365, and 256 mg/dl, respectively. The thyroid function test profile was that of euthyroidism, with serum FT4 of 1.41 (ig/dl, serum free L-thyronine (FT3) of 2.14 pg/dl, and TSH of 0.1 1 |j.U/ml. Anti-thyroidstimulating hormone receptor antibody was positive with a high titer (30%), and anti-microsomal antibody was also positive (x l 602). The test for antithyroglobulin antibody was negative, but that for anti-nuclear antibody (ANA) was positive (x640) with a speckled pattern. Noother autoantibodies, such as antiDNAantibody, anti-Sm antibody, anti-RNP antibody, anti-SS-A and SS-B antibodies or rheumatoid factor were detected. Lupus anticoagulant (LAC) and anticardiolipin antibody were also negative. The cold agglutinin reaction and the serological test for syphilis were negative. Her serum was negative for cryoglobulin, but cryofibrinogen was detected in citrated plasma. In the detection of cryofibrinogen, we used her citrated plasma, and samples were centrifuged at warm temperatures with subsequent cooling to 4°C. As Fig. 2 shows, the precipitate was visible at 4°C but it dissolved upon warming. The cryocrit was 18%.
Histological examination of a specimen from the left big toe ulcer showeddilatation in the majority of the superficial and deep dermal blood vessels with necrosis of the epidermis and dermis. Examination by laser Doppler flowmetry (2) revealed reduced blood flow of the toes, especially the left big toe, under cold conditions (Table lb) . As these findings revealed hypersensitivity to coldness, we made the diagnosis of symptomatic cryofibrinogenemia.
Treatment was started with prostaglandin El (PGE1, Limaprost altadex, opalmon®, 30 |a.g/day) and a low dose of acetylsalicylic acid (aspirin®, 8 1 mg/day). Her symptoms resolved on day 32 after the start of the additional drug administration (Fig. 3) . cryofibrinogenemia. According to the report by Kellett, cryofibrinogenemia was observed in 3.4 to 8.5% of outpatients (4). Smith and Arkin reported a prevalence of 3% for cryofibrinogenemia in their hospital patients (5) . Thus, cryofibrinogenemia is not an uncommon state. These reports also indicated, however, that most cases were asymptomatic. Zlotnick et al reported that the symptoms of this disease were cutis marmorata, Raynaud's phenomenon, acrocyanosis, acral necrosis, and hemorrhage (1) Grave's disease is an organ specific autoimmunedisease. There are several reports that methimazole therapy induces autoantibody production. Yoshikawaet al reported a case of insulin autoimmunesyndromeinduced by methimazole in a patient with Grave's disease (6) , and Gemmaet al reported a case of LDH-linked immunoglobulin in a patient with Grave's disease treated with methimazole (7). Euler et al reported a case of cryofibrinogenemia in which the cryofibrinogen was composed of fibrinogen and a monoclonal anti-fibrinogen antibody (IgG3K) (8) . Therefore, in the present patient, we cannot exclude the possibility that methimazole therapy contributed to the development of cryofibrinogenemia. The therapy that has been used for symptomatic cryofibrinogenemia includes heparin, warfarin, streptokinase, plasmapheresis, anabolic steroid, and immuno-suppressive therapy (9) . In patients with mild symptomsand signs, avoidance of cold exposure may be adequate.
We treated the present patient, who had a severe ulcer on her first toe, with acetylsalicylic acid as an anticoagulant, and prostaglandin as a vasodilator. This patient has been in remission with this therapy. Cryofibrinogenemia should be taken into consideration whenmaking a diagnosis of cryopathy in a patient with Graves' disease treated with methimazole.
